NDC11 82293003020
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 82293-0030-20 | 82293-0030 |
| 82293-030-20 | 82293-030 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| everolimus | EVEROLIMUS | Novugen Pharma (USA) LLC. | 67e62e26-448d-46ec-b5a1-00dc1b5e26c6 | 2026-03-10 | Warnings, Adverse reactions | 82293-030-20 82293-030 82293003020 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.